Skip to content

We're in Beta! Found a bug? Let us know using the feedback button at the bottom right.

FolioFact
FolioFact
Q3 2026 56/68 funds filed
Latest observation
Sign in Sign up

Some record dates are in the future and are excluded from the latest observation date.

Bessemer Venture Partners — TCRX

How Bessemer Venture Partners's position in Tscan Therapeutics, Inc. changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing.

Quarters held
20
First reported
Q4 2021
Latest value
$386,106
Latest weight
0.1%
Peak weight
1.8%
Shares since first
0%

Position Trend

Shares, value, and weight from first report to latest report.

Bessemer Venture Partners first reported 1,245,505 shares in Q4 2021 and most recently reported 1,245,504 shares in Q3 2026. Portfolio weight peaked at 1.8% in Q1 2024; the low reported weight was 0.1% in Q3 2026.

Since the first report, shares are 0% and reported value is -93.1%. Latest move: —

Quarter Shares Value % of portfolio Change
Q3 2026 1,245,504 $386,106 0.05% —
Q2 2026 1,245,504 $1,220,594 0.15% —
Q1 2026 1,245,504 $1,257,959 0.2% —
Q4 2025 1,245,504 $1,245,504 0.12% —
Q3 2025 1,245,504 $2,266,817 0.2% —
Q2 2025 1,245,504 $1,805,981 0.14% —
Q1 2025 1,245,504 $1,718,796 0.16% —
Q4 2024 1,245,504 $3,786,332 0.3% —
Q3 2024 1,245,504 $6,202,610 0.98% —
Q2 2024 1,245,504 $7,286,198 1.5% —
Q1 2024 1,245,504 $9,889,302 1.79% TRIM
Q4 2023 1,245,505 $7,261,294 0.94% —
Q3 2023 1,245,505 $3,188,493 0.39% —
Q2 2023 1,245,505 $3,113,763 0.28% —
Q1 2023 1,245,505 $2,615,561 0.24% —
Q4 2022 1,245,505 $1,930,533 0.18% —
Q3 2022 1,245,505 $3,799,000 0.27% —
Q2 2022 1,245,505 $3,917,000 0.25% —
Q1 2022 1,245,505 $3,487,000 0.12% —
Q4 2021 1,245,505 $5,605,000 0.14% Newly reported

Send feedback

Optional — tap one if it fits

We'll only use this to respond to your feedback.